Canal Insurance Company’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-200
Closed -$63K 73
2025
Q1
$63K Hold
200
0.01% 82
2024
Q4
$55K Sell
200
-100
-33% -$5.59K 0.01% 74
2024
Q3
$74K Hold
300
0.02% 89
2024
Q2
$39K Buy
+300
New +$13.4K 0.01% 84
2022
Q2
Sell
-475
Closed -$321K 102
2022
Q1
$321K Buy
+475
New +$31.9K 0.09% 75
2019
Q4
Sell
-50,000
Closed -$68K 62
2019
Q3
$68K Buy
+50,000
New +$2.35M 0.02% 61
2018
Q3
Sell
-55,000
Closed -$95K 76
2018
Q2
$95K Sell
55,000
-70,000
-56% -$3.78M 0.03% 63
2018
Q1
$325K Buy
125,000
+60,000
+92% +$3.86M 0.11% 58
2017
Q4
$93K Buy
65,000
+5,000
+8% +$313K 0.03% 68
2017
Q3
$130K Buy
+60,000
New +$3.5M 0.05% 72
2016
Q4
Sell
-22,000
Closed -$16K 89
2016
Q3
$16K Sell
22,000
-28,000
-56% -$1.8M 0.01% 100
2016
Q2
$180K Buy
+50,000
New +$3.53M 0.06% 88
2015
Q2
Sell
-40,000
Closed -$35K 88
2015
Q1
$35K Buy
+40,000
New +$2.5M 0.01% 82

Other funds holding BMY

Canal Insurance Company's BMY Position: Q2 2026 in Review

Canal Insurance Company held its Bristol-Myers Squibb (BMY) position steady in Q2 2026 at 170,000 shares worth $9.79M. The position accounts for 2.15% of the portfolio, ranked #14.

Canal Insurance Company first reported a position in BMY in Q2 2013 and has held it in 53 quarters since. The position peaked at $12.7M in Q2 2018. 1,717 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Canal Insurance Company held 170,000 shares of Bristol-Myers Squibb worth $9.79M as of Q2 2026.
  • Canal Insurance Company left its Bristol-Myers Squibb share count unchanged in Q2 2026.
  • Bristol-Myers Squibb made up 2.15% of Canal Insurance Company's portfolio in Q2 2026, its #14 holding.
  • Canal Insurance Company first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 53 quarters since.
  • Canal Insurance Company's Bristol-Myers Squibb position peaked at $12.7M in Q2 2018.
  • 1,717 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Canal Insurance Company's 13F filing for Q2 2026, filed 21 Jul 2026.